Will China have more phase 3 drug trials than the United States in year X?
One-OffSaúde e medicinaChina4aManifold MarketsSem KYCDados de resolução verificadosBem calibradoPrevisão da comunidade atual2030 69.2%Líder entre 5 opções
Previsores
3
Tipo de pergunta
multiple choice
Metodologia
Play-money forecasting platform
Tipo de fonte
Previsão
Variação 7d
0.0 pts
Dados do mercado
Atualizado há 11 horas
Desatualizado13/06/26, 23:07 UTC31/12/30, 23:59 UTC
Tendências
Mercados Relacionados
Perguntas relacionadas para dar contexto, não uma comparação de contratos equivalentes.
Will there be a ban on Chinese biotech trials by US-based companies by EOY2027?
Manifold MarketsWill a majority government owned company introduce a new GLP-1 drug before 2040?
Manifold MarketsEU adopts Chinese telecom gear phase-out law by which date?
PolymarketFDA decision: Ivonescimab by Summit Therapeutics (in 2026)
KalshiWill WW3 start before gta6?
Manifold MarketsWill Ice Cream turn out to actually be "healthy" based on consensus view at EOY 2026?
Manifold MarketsRegras
Resolution criteria
- This is an independent multiple-choice market.
- Each year will resolve independently as YES or NO based on whether China registers more Phase 3 clinical trials than the United States during that calendar year.
- Primary Source of Truth: The database compiled by the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP), specifically accessed via the WHO Global Observatory on Health Research and Development dashboard for "Number of clinical trial registrations by year, location, disease and phase of development".
- Resolution Rules:
- YES: If the final count of Phase 3 clinical trial registrations for China (as the trial location) is strictly greater than the count for the United States (as the trial location) for the given calendar year.